< Back to previous page
Researcher
Koen Raemdonck
- Disciplines:Nanobiotechnology, Environmental safety and health of nanotechnology, Nanoscale characterisation, Nanophotonics, Nanotechnology not elsewhere classified, Nanometrology, Drug discovery and development not elsewhere classified, Clinical trials, Other pharmaceutical sciences not elsewhere classified, Compound screening, In vitro testing, Biopharmaceuticals, Non-clinical studies, Molecular medicine, Vaccines, Nanomaterials, Nanomanufacturing, Nanofabrication, growth and self assembly, Nanoelectromechanical systems
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Oct 2004 → Today
Infrastructure
1 - 1 of 1
- Confocal and two-photon Microscope (Consortium partner)
Projects
1 - 10 of 18
- Exploring co-encapsulation of antihistamines and immune checkpoint siRNAs in lipid nanoparticles for cancer immunotherapy.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Conformationally locked G4-decoy oligonucleotides for selective telomerase inhibition and development of a nucleic acid-based anti-telomerase PROTAC strategyFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Synthesis of modified PNA probes for sequence-selective G-quadruplex photoalkylation.From1 Nov 2021 → TodayFunding: FWO Strategic Basic Research Grant
- REpurposing lung Surfactant Protein B for Inhalation therapy with RNA therapeuticsFrom1 May 2021 → TodayFunding: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
- Repurposing lung surfactant protein B for inhalation therapy with RNA therapeuticsFrom1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Stimulated emission depletion microscopy (STED): Nanoscopy for innovative research in the life sciencesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- NANOMED / Colloidally stable nanogel formulations for siRNA deliveryFrom1 Aug 2019 → 31 Jan 2020Funding: BOF - doctoral mandates
- Local immunomodulation of atherosclerosis by CD8+ T-cell based nanomedicinesFrom1 May 2019 → 30 Apr 2022Funding: FWO research project (including WEAVE projects)
- RNA-MAGIC: RNA-based bioMArkers and tarGets In asthma and Chronic Obstructive Pulmonary Disease (COPD)From1 Jan 2019 → TodayFunding: BOF - projects
- Combination cancer therapy by simultaneous delivery of cationic amphiphilic drugs and RNA therapeutics using a polymer delivery platformFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
Publications
81 - 87 of 87
- Interactions of siRNA loaded dextran nanogel with blood cells(2010)Volume: 148
Authors: Broes Naeye, Koen Raemdonck, Jo Demeester, Stefaan De Smedt, Wim Hennink
Pages: E90 - E91 - Advanced nanogel engineering for drug delivery(2009)
Authors: Koen Raemdonck
Pages: 707 - 715 - Biodegradable dextran nanogels as functional carriers for the intracellular delivery of small interfering RNA(2009)
Authors: Koen Raemdonck
- Biodegradable Dextran Nanogels for RNA Interference: Focusing on Endosomal Escape and Intracellular siRNA Delivery(2009)
Authors: Koen Raemdonck, Broes Naeye, Kevin Buyens, A Hogset
Pages: 1406 - 1415 - Dextran microgels for time-controlled delivery of siRNA(2008)
Authors: Koen Raemdonck, Tinneke Van Thienen, Roosmarijn Vandenbroucke, Niek Sanders, Jo Demeester, Stefaan De Smedt
Pages: 993 - 1001 - A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum(2008)
Authors: Kevin Buyens, Bart Lucas, Koen Raemdonck, Kevin Braeckmans, J VERCAMMEN, J HENDRIX, Y ENGELBORGHS, Stefaan De Smedt, Niek Sanders
Pages: 67 - 76 - Maintaining the silence: reflections on long-term RNAi(2008)
Authors: Koen Raemdonck, Niek Sanders
Pages: 917 - 931
Patents
1 - 7 of 7
- MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)
- MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)